Vector Control, Saving Lives

ivcc

IVCC is delighted to announce the appointment of Chris Larkin as Head of Communications and External Relations.  Prior to joining IVCC, Chris was Director of Communications at The University of Salford and preceding this, held senior communication positions at Marks & Spencer, Nationwide Building Society and WPP’s public relations arm, Hill + Knowlton Strategies.   

IVCC is to receive new funding of £25million from UKAID for its work developing new anti-malarial insecticides. The announcement was made by the Secretary of State for International Development, The Rt Hon Priti Patel MP, at the launch of the WHO World Malaria Report 2016 in London.

Despite growing mosquito resistance to insecticides, vector control remains the main way of preventing and reducing malaria transmission, says the WHO in its recently released World Malaria Report 2016.

'Long-lasting insecticidal nets are the mainstay of malaria prevention', said Secretary General, Margaret Chan, adding that the WHO recommends their use for all people at risk of malaria. 'Across sub-Saharan Africa, the proportion of people sleeping under treated nets has nearly doubled over the last 5 years', she said. 

Malaria rates halved throughout sub-Saharan Africa in the years between 2000 and 2015 as a consequence of greatly improved malaria interventions.

These impressive gains reflect a change of emphasis to make vector control a priority in malaria control programmes. Widespread distribution of insecticide-treated bednets made the biggest contribution, together with indoor residual spraying with insecticides through a coordinated control programme in 15 malaria endemic countries. Together these vector control interventions accounted for 78% of the gains.

The critical situation we are now facing with insecticide resistance in Africa is a direct consequence of underinvestment in public health insecticides. This bold statement by Professor Hilary Ransom of the Liverpool School of Tropical Medicine at the European Congress on Tropical Medicine and Health in Basel underlined her argument that we need urgently new insecticides if the amazing gains in malaria reduction are to be continued.

Keeping people healthy and creating prosperous communities is not only ethically sound, but also makes good business sense, said Sir Mark Moody-Stuart, Chairman of the IVCC Board of Trustees, addressing nearly 500 company leaders and executives at the Third Global Forum for Business as an Agent of World Benefit.

Keeping people healthy and creating prosperous communities is not only ethically sound, but also makes good business sense, said Sir Mark Moody-Stuart, Chairman of the IVCC Board of Trustees, addressing nearly 500 company leaders and executives at the Third Global Forum for Business as an Agent of World Benefit.

The Innovative Vector Control Consortium (IVCC) has helped the CREC/LSHTM Collaborative Research Programme in Benin achieve Good Laboratory Practice (GLP) certification, the second vector control field trial site to attain certification in Sub-Saharan Africa.

 The CREC/LSHTM Collaborative Research Programme is a research partnership set up in 2003 between the London School of Hygiene & Tropical Medicine and the Centre de Recherche Entomologique de Cotonou (CREC) at the Ministry of Health in Benin.

IVCC has welcomed the WHO Pre-Qualification of Bayer’s Fludora™ Fusion, combining different modes of action, as another major step forward in malaria control and insecticide resistance management.

IVCC supported the development of this new indoor residual spray (IRS) product in field trials where the product was tested against various resistant mosquito strains and on different relevant surface types. The data generated demonstrated that Fludora™ Fusion provides robust and consistent results, matching the needs of malaria control programs across Africa.

Senior Technical Manager

 

 

 

 

 

Derric manages the IVCC technical team and portfolio, evaluating new active ingredients and innovative vector control tools. The technical team works with industry and academic partners to bring innovative and sustainable tools for vector control to the market.

Xavier Lacour joined IVCC Access team end of January 2018 as Access Development Manager.
Xavier has 20+ years of experience in pharmaceutical industry, consulting and entrepreneurship. He has held various positions in Marketing, Market Access and Public Affairs at national and International level to prepare and execute the launch of 12 vaccines at SpMSD, Novartis Vaccines and GSK successively.

Pages